Your browser doesn't support javascript.
loading
The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Murdock, Kyle W; Wang, Xin Shelley; Shi, Qiuling; Cleeland, Charles S; Fagundes, Christopher P; Vernon, Suzanne D.
Afiliação
  • Murdock KW; Department of Psychology, Rice University, Houston, TX, USA.
  • Wang XS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1450, Houston, TX, 77030, USA. xswang@mdanderson.org.
  • Shi Q; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1450, Houston, TX, 77030, USA.
  • Cleeland CS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1450, Houston, TX, 77030, USA.
  • Fagundes CP; Department of Psychology, Rice University, Houston, TX, USA.
  • Vernon SD; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1450, Houston, TX, 77030, USA.
Qual Life Res ; 26(4): 913-921, 2017 04.
Article em En | MEDLINE | ID: mdl-27600520
ABSTRACT

PURPOSE:

Debilitating fatigue is a core symptom of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); however, the utility of patient-reported symptom outcome measures of fatigue for ME/CFS patients is problematic due to ceiling effects and issues with reliability and validity. We sought to evaluate the performance of three patient-reported symptom measures in a sample of ME/CFS patients and matched controls.

METHODS:

Two hundred and forty ME/CFS patients and 88 age, sex, race, and zip code matched controls participated in the study. Participants completed the Multidimensional Fatigue Inventory-20, DePaul Symptom Questionnaire, and RAND SF-36.

RESULTS:

The general and physical fatigue subscales on Multidimensional Fatigue Inventory-20, as well as the role of physical health on the RAND SF-36, demonstrated questionable or unacceptable internal consistency and problematic ceiling effects. The DePaul Symptom Questionnaire demonstrated excellent internal reliability, and less than 5 % of participants were at the ceiling on each subscale. The post-exertional malaise subscale on the DePaul Symptom Questionnaire demonstrated excellent clinical utility as it was able to differentiate between ME/CFS patients and controls (OR 1.23, p < .001) and predicted ceiling effects on other patient-reported outcome subscales. A score of 20 on the post-exertional malaise subscale of the DePaul Symptom Questionnaire optimally differentiated between patients and controls.

CONCLUSIONS:

Significant ceiling effects and concerns with reliability and validity were observed among Multidimensional Fatigue Inventory-20 and RAND SF-36 subscales for ME/CFS patients. The DePaul Symptom Questionnaire addresses a number of concerns typically identified when using patient-reported outcome measures with ME/CFS patients; however, an improved multidimensional patient-reported outcome tool for measuring ME/CFS-related symptoms is warranted.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Fadiga Crônica / Medidas de Resultados Relatados pelo Paciente Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Qual Life Res Assunto da revista: REABILITACAO / TERAPEUTICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Fadiga Crônica / Medidas de Resultados Relatados pelo Paciente Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Qual Life Res Assunto da revista: REABILITACAO / TERAPEUTICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos